Research

Hormonal

Intermittent rapamycin dosing (once every 5 days) mitigates glucose intolerance and beta-cell dysfunction while maintaining mTORC1 inhibition, compared to daily dosing.

If using rapamycin for longevity, consider an intermittent schedule (e.g., once every 5 days) rather than daily dosing. This approach appears to preserve the anti-aging benefits (mTORC1 inhibition) while significantly reducing the risk of glucose intolerance and beta-cell dysfunction seen with daily use. Consult a physician for dosing protocols.

GoodQualifiesHIGH confidence
We observed no effect of intermittent rapamycin on glucose tolerance, while daily rapamycin treatment caused a robust decrease in glucose tolerance... Rapamycin treatment once every 5 days (19/5 days) had the smallest impact on glucose tolerance, and we therefore selected this dosing schedule for further analysis.
Sebastian I. Arriola Apelo et al. · Aging Cell · 2015

Why this rating

Controlled animal study with clear mechanistic endpoints (GTT, PTT, HOMA, islet function) and statistical significance.

Source

Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system

Sebastian I. Arriola Apelo et al. · Aging Cell · 2015

DOI 10.1111/acel.12405

mechanism_onlyCited 182×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →